- Citations, last 5 years
- 2 745
- Works, last 5 years
- 74
- h-index
- 48
- Scientists listed
- 0
- Grants since 2016
- 15
Grants received
2025 · research · Spring 2025 RFA Seed Amplification Assay Innovation Program
Development of an Efficient Method to Capture Synuclein Seeds from Biological Samples for Detection Using SynSAA
Luis Concha · Amprion (United States) · funded by Michael J. Fox Foundation for Parkinson's Research
2023–2024 · research · Biomarkers
Evaluation of the Clinical Utility of α-Synuclein Seed Amplification Assay as an Aid in the Diagnosis of Dementia and Differentiation of Dementia Subtypes
Russell Lebovitz · Amprion (United States) · funded by Alzheimer's Drug Discovery Foundation
2021–2023 · cooperative agreement · U44
Analytical validation of a biochemical test for alpha-synuclein aggregates in biological fluids for the diagnosis of Parkinson's Disease
Karen Macleod · Amprion (United States) · funded by National Institutes of Health
2021–2023 · cooperative agreement · U44
Analytical validation of a biochemical test for alpha-synuclein aggregates in biological fluids for the diagnosis of Parkinson's Disease
Karen Macleod · Amprion (United States) · funded by National Institutes of Health
2021 · research · Alpha-synuclein Seed Amplification Assay Program
Development of a Simplified, Rapid Method for Measuring Alpha-synuclein in Clinical Samples
Luis Concha · Amprion (United States) · funded by Michael J. Fox Foundation for Parkinson's Research
2021–2022 · research · Biomarkers
Misfolded Alpha-Synuclein Aggregates in CSF as Diagnostic & Prognostic Markers for Dementia
Russell Lebovitz · Amprion (United States) · funded by Alzheimer's Drug Discovery Foundation
2020–2021 · cooperative agreement · U44
Analytical validation of a biochemical test for alpha-synuclein aggregates in biological fluids for the diagnosis of Parkinson's Disease
Karen Macleod · Amprion (United States) · funded by National Institutes of Health
2020–2021 · research · Diagnostics Accelerator
Development and Commercialization of a Protein Misfolding Cyclic Amplification (PMCA) Clinical Test for Detection of Aggregates of Misfolded α-Synuclein in Plasma and Plasma Exosomes
Russell Lebovitz · Amprion (United States) · funded by Alzheimer's Drug Discovery Foundation
2018–2019 · research · R42
Highly selective detection of tau oligomers in biological fluids for the diagnosis of Alzheimer's Disease
Claudio Soto · Amprion (United States) · funded by National Institutes of Health
2018–2021 · research · R42
Highly selective detection of tau oligomers in biological fluids for the diagnosis of Alzheimer's Disease
Claudio Soto · Amprion (United States) · funded by National Institutes of Health
2018–2022 · research · R42
Highly selective detection of tau oligomers in biological fluids for the diagnosis of Alzheimer's Disease
Claudio Soto · Amprion (United States) · funded by National Institutes of Health
2016–2019 · grant · SB1
Development of a Biochemical Diagnosis for Creutzfeldt-Jakob disease
Russell M Lebovitz · Amprion (United States) · funded by National Institutes of Health
2016–2019 · research · R42
Blood-based diagnostics for Alzheimer's Disease
Claudio Soto · Amprion (United States) · funded by National Institutes of Health
2016–2018 · grant · SB1
Development of a Biochemical Diagnosis for Creutzfeldt-Jakob disease
Russell M Lebovitz · Amprion (United States) · funded by National Institutes of Health
2016–2018 · research · R42
Blood-based diagnostics for Alzheimer's Disease
Claudio Soto · Amprion (United States) · funded by National Institutes of Health